Inhibikase Therapeutics logo
Inhibikase Therapeutics IKT
$ 2.96 -7.5%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Inhibikase Therapeutics Total Current Liabilities 2011-2024 | IKT

Annual Total Current Liabilities Inhibikase Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
3.44 M 3.7 M 4.05 M - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
4.05 M 3.44 M 3.73 M